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ABSTRACT 
Motivation: Myogenesis is a complex process controlled by different networks, depending on the origin of different muscles, 
and that’s why there are different types of muscle distrophies. However, the myogenic cascade is always regulated by the 
same Myogenic Regulatory Factors (MRFs): Myf5, Mrf4, MyoD and MyoG. These transcription factors bind DNA and activate 
the expression of specific genes in particular progenitor cells that will give rise to the different muscles in the adult body. The 
MRFs’ cascade is initiated by Myf5, the first MRF to be expressed in the embryo. We and others have extensively studied the 
complex transcriptional regulation of the Myf5/Mrf4 locus using transgenic mice. Nowadays, we know that there are more than 
25 regulatory elements controlling the expression of Mrf4 and Myf5 in a specific time frame and in particular embryonic 
progenitors. 
The limb enhancer is located 57 kb upstream of the Myf5 transcriptional start site. This enhancer controls Myf5 expression in 
limbs during development. While the mechanisms involved in the spatiotemporal regulation of Myf5 have been extensively 
studied at single-enhancer and global regulatory levels, the function of Myf5 in different subpopulations of muscle progenitor 
cells is still not clear. This project focuses on the characterization of a new allele in which the limb enhancer has been removed 
from the genome. 
Methods: To unravel the function of Myf5 in the developing limb musculature we have generated a new knock-out (KO) allele 
with CRISPR/Cas9 in which the limb enhancer has been targeted. Then, we have prepared RNA probes for In Situ 
Hybridisation (ISH) of genes that are expressed in limbs and are potential targets of Myf5 in other muscle progenitors (López-
Mayorga et al., unpublished data), to test if the expression patters of these genes are modified in the KO allele. We are going 
to study three different embryonic stages: 10.5, 11.5 and 12.5 days post-coitum (dpc) by ISH using KO and wild type (WT) 
embryos. This time window was chosen to maximise the probability of detecting any pattern changes before the phenotype is 
rescued by the activity of MyoD, as previously shown. We are also preparing total RNA of fore-limbs from KO and WT 
embryos at 11.5 dpc to perform microarrays, which will give us some information about the genes regulated by Myf5 direct or 
indirectly. Finally, we will validate the results from microarrays by ISH and qPCR. 
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